As an alternative, Speakman has put forward a non-adaptive scenariothe drifty gene hypothesis. According to this idea, genetic drift -the change of gene frequencies due to random, non-selective processes-could explain the current incidence of obesity seen in modern, industrialized populations. Speakman has hypothesized that the threat of predation on early humans may have provided a strong selective pressure to keep maximum body weight in check. A human fleeing from a sabertooth cat, for example, would be at a clear disadvantage if they carried extra weight. The introduction of fire and cooperative social groups may have reduced the threat of predation, allowing upper body weight to wander through genetic drift. The effects of genetic drift are most profound in small populations, but Speakman argues that just such a process could explain the accumulation of mutations in the human population that affect body weight.
Future outlook
Testing ideas such as the thrifty and drifty gene hypotheses will depend greatly on a better understanding of the genetic basis of obesity. There is no doubt that genetics factors heavily, as it is has been estimated that 40-70% of the variability in body-mass index can be explained by genetic differences. As in other polygenic traits studied, however, the contribution of the few genes identified appear to be rather small. Such genes, satisfyingly, appear to be involved in the signaling pathways that control feeding and energy storage. As more genes are identified, it will be interesting to see if there is any evidence that natural selection has operated on obesity genes or whether, if Speakman is correct, neutral evolutionary processes were at work. However, given that most genes have many different functions, the existence of such genes in the population may after all also reflect selection on a completely different trait than body mass.
Whatever progress is made on the genetics of obesity, it is clear that environmental factors are equally crucial. That obesity was rare in the US and elsewhere nearly a century ago makes this obvious. Something in our environment has conspired with our genes to produce the current situation. As noted, the animal work suggests that the influx of energy-dense food, characterized by high fat and refined sugars, is likely to induce obesity. But what about the claim that our couch-potato lifestyle is a contributing factor? Surprisingly, recent research calls this idea into doubt. In June, a paper from Pontzer and colleagues (PLoS ONE (2012) 7, e40503) reported that the average daily energy expenditure of a hunter-gather group, the Hadza people living in East Africa, is not significantly different from that of numerous industrialized populations, including Americans. This is despite the fact that the Hadza, as expected, are much more physically active than their western counterparts.
Why this should be is uncertain, but if the results hold up, it suggests that diet rather than physical activity may be a more important component of obesity. Sadly, this is consistent with the demographics of obesity, as the poor, for whom a high-fat diet is the cheapest option, exhibit the highest rates of obesity. In some ways it seems we are a victim of our own success. Advances in agriculture and food processing has brought an abundance of cheap food to the table. Thus, while many in the world are malnourished, industrialized nations have swung to the other extreme, but in the process we have forgotten that the quality of the food is just as important as the quantity.
Turning back to the question of the link between our evolutionary history and obesity, there are no clear answers as yet. We do know that humans have evolved in response to the food in their environment. What's less clear is whether obesity is best seen as a discordance between previous adaptations and our modern environment, as in sickle cell anemia. There is certainly scope for such disharmony. In particular, our modern culture is changing so quickly, it's difficult to imagine how evolution could keep up, especially given that modern medicine undoubtedly reduces the main agent of evolution -natural selection. While frightening for most people, perhaps this scenario is comforting for those that have always wished for a simpler life, free of Big Macs, escalators, and work cubicles.
Cyrus Martin is Senior Scientific Editor for Current Biology.
Rapid population rise bad for our health?
Research suggests that the rapid population growth of our species in the last 10,000 years has produced a kind of genetic variability for which traditional models of population genetics are inadequate. But do the new findings solve the missing heritability problem emerging from genome-wide association studies? And does the phenomenon put our species at risk? Michael Gross investigates.
The ongoing 'genome revolution' has had no shortage of discoveries. New methods like genome-wide association studies (GWAS) have raked in hundreds and thousands of associations between genetic traits and medically relevant phenotypes in the last five years. From the headlines reporting new discoveries, one would think that we are living in a golden age of medical research and all our ills will become curable very soon.
However, a much more sober view prevails as soon as one looks at a specific disorder and sums up which fraction of the case number is accounted for by the genetic discoveries. In autism, for instance, the genes linked to the condition so far only explain a single figure percentage of the cases, even though twin studies suggest that the heritability is much higher (Curr. Biol. (2011) 21, R571-R573). A similar situation is observed for all other complex diseases that have genetic contributory factors, including cancers, diabetes, and heart disease.
Epigenetics may explain part of the heredity that does not show up in linkage studies, and combinations of frequent mutations that individually only have very weak effects may also play a role. However, recent discoveries have pointed a spotlight on a possible explanation that has so far been underappreciated: mutations that are so rare that they fell through the grid in the first systematic searches for medically relevant polymorphisms.
abundance of rare variants
Several studies published this year have pointed to a surprisingly high number of rare variations in the human genome, which are defined as variations that affect less than 0.5% of individuals in a population. By contrast, previous studies of human genetic diversity have typically focused on variants that affect at least 1% of the population, such as SNPs (single nucleotide polymorphisms).
In February, an international collaboration led by Daniel MacArthur at the Sanger Institute near Cambridge, UK, surveyed variants in protein-coding genes that lead to loss of protein function (Science (2012), 335, 823-828). The authors calculated that a typical human genome will contain around 100 loss-of-function variants, and around 20 genes will be knocked out completely. They conclude that the human genome must be more robust towards gene disruption than had been previously thought.
In May, Alon Keinan and Andrew Clark from Cornell University linked the high number of rare variants to the rapid population growth in the last 10,000 years (Science (2012) 336, 740-743). Following the introduction of agriculture, the world population grew by more than three orders of magnitude in less than 400 generations. In the last 1,000 years, growth was even faster with one doubling every 10 generations, and the growth rate peaked in 1962-1963 with 2.2% per annum. For population genetics, the 'effective population size' is the crucial parameter, which is typically smaller than the actual number of individuals, but which has grown just as dramatically in the last 10,000 years.
The 1,000-year measure of one doubling per ten generations may not seem extreme if you consider individual families, which may grow much faster. However, as a sustained expansion across the whole population it is sufficient to derail current models of population genetics that rely on a steady-state situation, and on which previous analysis of human genetic diversity and disease patterns had been based.
"Everybody was obviously aware of the recent growth of human populations, but the effects on patterns of genetic variation have not been incorporated -till the recent series of papers -into models," explains Keinan. "The main reason is that thus far researchers have been only able to consider relatively small samples of individuals, in which the effects of growth are not apparent. There are theoretical population genetic models that account for exponential population growth, but these are not applicable to a scenario in which the exponential growth starts only in relatively recent history, after a period characterized by less fluctuation in population size. This scenario raises new modelling challenges."
The rapid population growth of the human race was preceded and accompanied by its spread across a broad variety of habitats, from the tropics to the polar regions, during the last 100,000 years. The extent to which the diversity of human phenotypes reflects adaptation to the different habitats is still being investigated, as Jonathan Pritchard from the University of Chicago has reported in a recent review in this journal (Curr. Biol. (2010) , 20, R208-R215).
In that time frame, additional layers of complexity come in with the evolutionary history of our species and the questions surrounding admixture of related subspecies such as Neanderthals and Denisovans. While the first analysis of the Neanderthal genome suggested that non-Africans carry up to 4% Neanderthal DNA (see Curr. Biol. (2011) , 21, R872), a recent publication has challenged that figure (Proc. Natl. Acad. Sci. USA (2012) 109, doi: 10.1073/pnas.1200567109).
Two further studies published in July highlighted the abundance of rare mutations in the human genome. A sequencing consortium led by Michael Bamshad and Joshua Akey at the University of Washington at Seattle sequenced the largest part of the protein-coding genes (i.e. the exome) of 2,440 individuals of either African or European ancestry (Science (2012) 337, 64-69). They discovered more than half a million single-nucleotide variants, of which 86% were rare in that their frequency was below 0.5%. They predict that more than 300 proteins per genome would be affected.
Using demographic modelling, they attribute this high number of rare variants to the rapid population growth. The models pinpoint the onset time for the relatively recent population explosion responsible for the phenomenon to around 5,000 years ago. The analyses also show that linking any such mutations to complex diseases will require the sequencing of much larger numbers of genomes.
In a separate paper that appeared simultaneously, the groups of Matthew Nelson at GlaxoSmithKline and John Novembre at the University of California at Los Angeles analysed rare variants in a larger number of people focusing on a smaller number of genes (Science (2012) 337, 100-104). Specifically, they sequenced 202 genes coding for drug targets in more than 14,000 individuals.
They also find a remarkably large number of variants, with every 17 th base being affected. More than 95% of them were below the 0.5% threshold defining rare variants. These are typically restricted to local populations, indicating that much larger and populationspecific association studies will be necessary to link such variants to diseases.
Both studies also point to rapid population expansion and relatively weak selection as a cause of the high variability. "With more individuals in the population due to recent rapid human growth, there have been more opportunities for mutations to arise in the recent past. The resulting variants are young and very rare, and we only see them with large sample sizes," Novembre explains. Weak selection, he says, means "that variants that are not immediately removed from a population will typically be kept at low frequencies."
Mind the gap
But does the discovery of genetic variability that had so far remained hidden and its attribution to the rapid population expansion in the last 10,000 years help to solve the missing heritability problem for complex diseases? So far, there have been three main schools of thought on this problem, favouring either rare mutations, or low-impact common mutations, or combinations of additional factors such as epigenetic regulation as the most likely area where an explanation may be found.
Experts agree that the recent findings have strengthened the case for looking more closely at rare mutations in the quest for an explanation. "Appreciation of the population expansion provides higher likelihood of the hypothesis that many different rare variants contribute to complex disease risk," says Alon Keinan. "This, in turn, might explain why so far the explanation gap has been as large as it is, given that genomewide association studies to date considered mostly common variants. It also entails that different methods, some of which are already being put into place, are needed to be able to associate rare variants with disease risk or other traits, but in any case associating rare risk variants is a much taller order than associating common variants; as they are rare, a larger sample size is needed to observe them, and a much reduced statistical power is expected for variants only observed in a few copies."
While researchers agree that the importance of rare variants has risen, it is difficult to predict where the balance between the different influences will ultimately be found. "My personal intuition is that rare variants will make a significant contribution to human phenotypic variation, but I do not feel comfortable hazarding a guess as to what 'significant' will turn out to be," says Joshua Akey from the University of Washington.
New technologies are promising further insights into the complexities of human genetic diversity. "One other point is that there is a third class of variant that people are chasing now with the next generation of target arrays that contain 'all' of the variation for metabolism or immunology typed at variants down to 1% minor allele frequency," Greg Gibson from the Georgia Institute of Technology at Atlanta points out. "This is the so-called 'goldilocks' variation, moderate effects at low frequency. Rare variants of large effect are popping out of resequencing studies; GWAS found common variants of small effect; in between we expect the goldilocks variants may fill in some of the missing heritability. The metabochip and immunochip are being applied to samples in the hundreds of thousands for a wide range of diseases now."
For specific diseases, the role of rare variants may even be impossible to quantify, warns Jaume Bertranpetit from the Universitat Pompeu Fabra at Barcelona, Spain. "If the variant is rare, as all inferences are statistic, based on variants of susceptibility, we need the power given by numbers," Bertranpetit explains. "In rare variants we may never have enough cases with or without the variant to claim an association: sample sizes should be huge and maybe there are not enough cases. And there is an additional problem: the bigger the sample size, the more heterogeneous the population will be, both for cases and controls, and thus there will be more population stratification, which is known to give false positive results."
Bad for our health?
The recent papers have also shown that a surprisingly large number of the newly discovered rare variants actually affect the function of the corresponding gene products. However, Greg Gibson cautions that the results can't tell us yet "whether these rare variants are promoting disease disproportionately, because we really have little idea about how variable their effects, or those of common variants, are among people. Evolutionary and structural inference suggests that many of them are likely to be deleterious, but we have to keep in mind that there is an enormous capacity of the genome to buffer the effects of variation."
Some have warned that the continuing accumulation and spread of deleterious mutations could spell trouble for the health of future generations. For instance, Michael Lynch from Indiana University at Bloomington, US, used his inaugural article as a new member of the National Academy of Sciences (Proc. Natl. Acad. Sci. USA (2010) 107, 961-968) to warn "that a substantial reduction in human fitness can be expected over the next few centuries in industrialized societies unless novel means of genetic intervention are developed."
Other researchers have concluded that, quite on the contrary, the presence of large numbers of variants in healthy individuals shows that the human genome has a level of robustness towards disease that has so far been underappreciated. Greg Gibson has described this phenomenon as 'decanalisation' based on the concept from population genetics, where individuals in a canalised population tend to stay very close to the optimal phenotype (Nat. Rev. Genet. (2009) 10, 134-140) .
The majority view seems to be that genetic meltdown isn't imminent yet. "Many of these arguments rely on the concept of genetic load, which can be parameterized in different ways, giving potentially different results," says Joshua Akey. "It seems to me, if we want to worry about human extinction, we should be more concerned about climate change, wars, and other man-made problems."
Michael Gross is a science writer based at Oxford. He can be contacted via his web page at www.michaelgross.co.uk
Essay Thomas W. abrams
The relative simplicity of Aplysia's nervous system and the ease with which changes in its identified neurons can be shown to participate in specific behavioral changes have enabled a rich series of discoveries about fundamental mechanisms of neuronal plasticity. In addition, the clear, direct link between neuronal plasticity in Aplysia and behavior frequently enables insights into functional roles of cellular and molecular processes that would otherwise be missed. Researchers studying simpler model systems such as Aplysia frequently put their research in the context of the challenges of understanding human diseases and suggest that insights gained in these more readily analysable systems may ultimately lead to advances in the treatment of clinical disorders. For example, in describing a novel molecular mechanism that underlies an attention-like process in Aplysia, which was understood precisely because of the direct link between synaptic plasticity and behavior, we recently suggested that this mechanism may also contribute to attentional processes in mammals [1] . The link between basic biology and disease is epitomized by the transcription factor CREB. The initial For decades, the marine snail Aplysia has proven to be a powerful system for analyzing basic neurobiological mechanisms, particularly cellular and molecular mechanisms of neural plasticity. Three new findings on Aplysia may be relevant for the understanding and treatment of chronic human disorders. This research on this simple molluscan nervous system may lead to new therapeutic approaches for spinal cord injury, Fragile X syndrome, and genetic learning deficits more generally.
Studies on Aplysia neurons suggest treatments for chronic human disorders
